01807nam a2200301Ia 4500 MX-MdCICY 20260521091737.0 CICY B-20598 Analyzing 3D structures of the SARS-CoV-2 main protease reveals structural features of ligand binding for COVID-19 drug discovery Drug Discovery Today, 28(10), p.103727, 2023 The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)main protease has an essential role in viral replication and has become a major target for coronavirus 2019 (COVID-19)drug development. Various inhibitors have been discovered or designed to bind to the main protease. The availability of more than 550 3D structures of the main protease provides a wealth of structural details on the main protease in both ligand-free and ligand-bound states. Therefore, we examined these structures to ascertain the structural features for the role of the main protease in the cleavage of polyproteins, the alternative conformations during main protease maturation, and ligand interactions in the main protease. The structural features unearthed could promote the development of COVID-19 drugs targeting the SARS-CoV-2 main protease. COVID-19 SARS-COV-2 CONFORMATIONS DRUG DISCOVERY AND DESIGN INHIBITOR MAIN PROTEASE PROTEIN-LIGAND INTERACTIONS Xu, L. Chen, R. Liu, J. Patterson, T. A. Hong, H. https://drive.google.com/file/d/1uv4e6Ik-LFToq--30D8tv5gWvO9pazb2/view?usp=drivesdk Para ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx Loc REF1 250602s9999 xx |||||s2 |||| ||und|d 30623 30623 0 0 Loc 0 0 F1 CICY CICY RE 2025-06-25 0 B-20598 2025-06-25 16:24:52 2025-06-25 REF1